30
Participants
Start Date
August 31, 2001
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Irinotecan (Camptosar, CPT-11)
"Cohort #1--Irinotecan 750 mg/m2 IV over 90 minutes Q 3 weeks x 15 patients; Cohort #2--Irinotecan 500 mg/m2 IV over 90 minutes Q 2 weeks x 3 patients; Cohort #3--Irinotecan 600 mg/m2 IV over 90 minutes Q 2 weeks x 3 patients.~Additional increments of 50 mg/m2 for subsequent cohorts until MTD is reached."
Kentuckiana Cancer Institute, Louisville
Kentuckiana Cancer Institute
OTHER